Xenon Pharmaceuticals Inc (NASDAQ:XENE)
| 17.16 Delayed Data As of 3:59pm ET |  -0.49 / -2.78%Today’s Change | 9.32 Today|||52-Week Range 21.94 | +11.57% Year-to-Date |
Latest XENE News | Press Releases
No recent news for Xenon Pharmaceuticals Inc.
Today’s Trading
| Previous close | 17.65 |
| Today’s open | 17.61 |
| Day’s range | 17.16 - 17.67 |
| Volume | 3,043 |
| Average volume (3 months) | 168,657 |
| Market cap | $745.2M |
Data as of 3:59pm ET, 07/30/2021
Growth & Valuation
| Earnings growth (last year) | +47.44% |
| Earnings growth (this year) | -89.99% |
| Earnings growth (next 5 years) | +61.10% |
| Revenue growth (last year) | +371.02% |
| P/E ratio | NM |
| Price/Sales | 16.52 |
| Price/Book | 3.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNDXSyndax Pharmaceutica... | -0.18 | -1.22% |
| GTHXG1 Therapeutics Inc | -0.07 | -0.40% |
| AERIAerie Pharmaceutical... | -0.10 | -0.63% |
| SMMTSummit Therapeutics ... | -0.34 | -4.43% |
Data as of 3:59pm ET, 07/30/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $32.2M |
| Annual profit (last year) | -$28.8M |
| Net profit margin | -89.65% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Burnaby, British Columbia |
Forecasts
